Richard Wagner
Chief Executive Officer at Bonito Biosciences
Net worth: - $ as of 2024-04-29
Profile
Richard W.
Wagner was the founder of X-Chem, Inc. (Massachusetts) founded in 2009, Zebiai Therapeutics, Inc. founded in 2019, and Bonito Biosciences founded in 2022, where he held the title of Chief Executive Officer.
He also held the position of Executive Vice President-Discovery Research at Praecis Pharmaceuticals, Inc. and served as an Independent Director at Eterna Therapeutics, Inc. for the year 2023.
Dr. Wagner holds a doctorate degree from Brown University and an undergraduate degree from Trinity College (Connecticut).
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
ETERNA THERAPEUTICS INC.
-.--% | 2023-07-12 | 0 ( -.--% ) | - $ | 2024-04-29 |
Richard Wagner active positions
| Companies | Position | Start |
|---|---|---|
| Bonito Biosciences | Chief Executive Officer | 2022-05-31 |
Former positions of Richard Wagner
| Companies | Position | End |
|---|---|---|
| ETERNA THERAPEUTICS INC. | Director/Board Member | 2023-08-07 |
X-Chem, Inc. (Massachusetts)
 X-Chem, Inc. (Massachusetts) Packaged SoftwareTechnology Services X-Chem, Inc. operates as a biotechnology company. Its uses its DEX DNA encoded libraries and platform to discover small molecule leads against high-value therapeutic targets. The company was founded by Richard W. Wagner, Brant C. Binder, Matthew A. Clark, and Gordon M. Binder in 2009 and is headquartered in Waltham, MA. | Chief Executive Officer | 2020-06-02 |
Zebiai Therapeutics, Inc.
 Zebiai Therapeutics, Inc. Packaged SoftwareTechnology Services Zebiai Therapeutics, Inc. develops artificial intelligence to predict and optimize novel small molecule modulators for challenging drug targets. The company was founded by Richard Wagner and is headquartered in Chestnut Hill, MA. | Chief Executive Officer | - |
Praecis Pharmaceuticals, Inc.
 Praecis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Praecis Pharmaceuticals, Inc. develops drugs and therapies for the treatment of cancer. The firm also develops peptide-based drugs. The company was founded 1993 and is headquartered in Waltham, MA. | Chief Tech/Sci/R&D Officer | - |
Training of Richard Wagner
| Brown University | Doctorate Degree |
| Trinity College (Connecticut) | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| ETERNA THERAPEUTICS INC. | Health Technology |
| Private companies | 4 |
|---|---|
Praecis Pharmaceuticals, Inc.
Praecis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Praecis Pharmaceuticals, Inc. develops drugs and therapies for the treatment of cancer. The firm also develops peptide-based drugs. The company was founded 1993 and is headquartered in Waltham, MA. | Health Technology |
X-Chem, Inc. (Massachusetts)
X-Chem, Inc. (Massachusetts) Packaged SoftwareTechnology Services X-Chem, Inc. operates as a biotechnology company. Its uses its DEX DNA encoded libraries and platform to discover small molecule leads against high-value therapeutic targets. The company was founded by Richard W. Wagner, Brant C. Binder, Matthew A. Clark, and Gordon M. Binder in 2009 and is headquartered in Waltham, MA. | Technology Services |
Zebiai Therapeutics, Inc.
Zebiai Therapeutics, Inc. Packaged SoftwareTechnology Services Zebiai Therapeutics, Inc. develops artificial intelligence to predict and optimize novel small molecule modulators for challenging drug targets. The company was founded by Richard Wagner and is headquartered in Chestnut Hill, MA. | Technology Services |
| Bonito Biosciences |
- Stock Market
- Insiders
- Richard Wagner
